NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Hoffmann-La Roche
Conditions: Ovarian Cancer
Interventions: Bevacizumab, Paclitaxel, Carboplatin
Countries: Brazil, France, Italy, Netherlands, Norway, Russia, Spain, Sweden
This single arm study evaluated the efficacy and safety of first-line chemotherapy with carboplatin and dose-dense weekly paclitaxel plus bevacizumab (Avastin) in participants with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Participants received 6-8 3-week cycles of treatment with bevacizumab 7.5 mg/kg intravenously (iv) on Day 1 of each cycle, paclitaxel 80 mg/m\^2 iv on days 1, 8, and 15 of each cycle, and carboplatin iv to an area under the curve (AUC) of 6 on day 1 of each cycle. Following combination chemotherapy, bevacizumab could be continued to be given as a monotherapy.
Sex: FEMALE
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria * Female patients, ≥ 18 years of age. * Epithelial ovarian, fallopian tube, or primary peritoneal cancer. * Initial surgery, but no chemotherapy or radiotherapy. * Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Exclusion Criteria * Non-epithelial tumors. * Ovarian tumors with low malignant potential. * Previous systemic anti-cancer therapy for ovarian cancer. * History or evidence of synchronous primary endometrial cancer. * Current or recent daily treatment with aspirin (\> 325mg/day) or with full dose anticoagulant or thrombolytic agents for therapeutic purposes.
- Jaú, São Paulo, Brazil
- São Paulo, São Paulo, Brazil
- Avignon, France
- Bordeaux, France
- Bordeaux, France
- Brive-la-Gaillarde, France
- Clamart, France
- Dijon, France
- Gap, France
- Grenoble, France
- Marseille, France
- Metz-Tessy, France
- Nice, France
- Paris, France
- Paris, France
- Poitiers, France
- Saint-Priest-en-Jarez, France
- Strasbourg, France
- Toulouse, France
- Vandœuvre-lès-Nancy, France
- Naples, Campania, Italy
- Modena, Emilia-Romagna, Italy
- Rome, Lazio, Italy
- Campobasso, Molise, Italy
- Alkmaar, Netherlands
- Amsterdam, Netherlands
- Enschede, Netherlands
- Groningen, Netherlands
- Leidschendam, Netherlands
- Tilburg, Netherlands
- + 25 more on CT.gov